INSIGHTS ON LIQUID DOSE MANUFACTURING

• A Risk-Based Decision Framework For Selecting Aseptic Barrier Technologies

  EU GMP Annex 1 requires a risk-based approach to selecting Isolators or RABS. This framework evaluates human intervention and decontamination to ensure robust sterility assurance.

• Empowering Innovation: Harnessing CDMO Potential For Sterile Injectables

  Specialized CDMOs are essential for meeting the growing demand and complex quality requirements for sterile injectables. Outsourcing provides crucial benefits like cost savings, flexibility, and a strategic focus on core competencies.

• From Complexity To Confidence: Supporting Tech Transfer With A Prefillable Syringe System

  Discover how aligning packaging strategy with technology transfer requirements can accelerate timelines, control costs, and support successful injectable drug product manufacturing.

• Sterile Injectables: Why Innovation Matters More Than Ever

  New technologies and regulatory changes are shaping safer, more efficient filling processes. Discover why innovation is key to protecting patients and advancing therapies.

• Redefining Prefillable Syringe System

  5/21/2026

  See how our Synchrony S1 pre-fillable syringe system delivers an integrated, system-level solution designed for performance, quality, and scalability — with simplified submissions, synchronized supply, and compatibility across the drug delivery ecosystem.

• Maximize Quality Assurance Through Rapid Sterility Testing

  9/10/2024

  This webinar explores mitigating the risk of product loss, and production delays, as well as the critical role rapid sterility testing plays in ensuring the quality and safety of cell therapy products.

• Start With An Integrated, Verified PFS System

  5/21/2026

  Synchrony S1 PFS system delivers an integrated, verified solution designed to streamline submissions, support reliable supply, and reduce development risk.

• Generate CHO-K1 GFP-Expressing Cells For Cell Line Development Workflow

  11/7/2025

  Discover a high-efficiency workflow for generating GFP-expressing CHO-K1 clones using automated single-cell dispensing to achieve 93% isolation success and stable expression in under five weeks.

• How DFM Promotes Scalability, Repeatability, And Profitability

  6/28/2024

  Find out why it is critical that OEMs see and understand the benefits of taking time to build a mold or create automation more robustly to achieve long-term savings and higher annual production.